HepatologyNews.net

Hepatology Xagena

Search results for "Chronic hepatitis C"

More than half of 61 children and adolescents infected with chronic hepatitis C achieved a sustained viral response after treatment with Peginterferon-alfa-2b ( Peg-Intron ) and Ribavirin ( Rebetol ). ...


The FDA ( Food and Drug Administration ) approved Pegasys ( Peginterferon alfa-2a ) for the treatment of chronic hepatitis B ( CHB ). Pegasys is the first and only pegylated Interferon approved fo ...


Patients with the most common form of hepatitis B in the United States who are treated with Pegasys ( Peginterferon alfa-2a ) are more likely to achieve a sustained response than those treated with La ...


Nearly half of 118 children with chronic Hepatitis C virus ( HCV ) treated with a combination of Interferon-alpha-2b ( Intron A ) and an optimized dose of Ribavirin ( Rebetol ) achieved sustained vira ...


A study in Japan examining the effects of combination therapy on older patients with hepatitis C found more adverse effects necessitating discontinuation of treatment, lowering of dosages, and lower l ...


Hepatic fibrosis, the common response associated with chronic liver diseases, ultimately leads to cirrhosis. Researchers showed that activation of hepatic cannabinoid CB2 receptors limits progression ...


Individuals with chronic hepatitis C being treated with Interferon ( IFN ) are at risk of developing retinopathy as early as two weeks into treatment according to the results of a study published in t ...


Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of liver disease progression than non-coffee drinkers.The study found ...


For patients with the most common form of hepatitis C, the addition of a hepatitis C–specific protease inhibitor called Telaprevir to the current standard therapy can significantly improve the chances ...


Sexual impairment is common among men with chronic hepatitis C undergoing antiviral therapy, according to a new study published in Gastroenterology.This is the first time a study evaluating the combin ...


Researchers at Cedars-Sinai Medical Center and 50 other Centers found that weight-based dosing of Taribavirin ( Viramidine ) reduces rates of anemia while increasing sustained virologic response ( SVR ...


The results from four Phase 3 clinical trials ( NEUTRINO, FISSION, POSITRON and FUSION ) evaluating Sofosbuvir ( Sovaldi ), an investigational once-daily nucleotide NS5B inhibitor for the treatment of ...


All-oral combination therapy is desirable for patients with chronic hepatitis C virus ( HCV ) infection. Researchers evaluated Daclatasvir ( an HCV NS5A replication complex inhibitor ) plus Sofosbuvir ...


Interferon-free regimens would be a major advance in the treatment of patients with chronic hepatitis C virus ( HCV ) infection.In the phase 2b, randomized, open-label trial of Faldaprevir ( a proteas ...


Low-dose oral Interferon could exert immune-modulating effects in human. Researchers have conducted a clinical trial to investigate the efficacy of oral Interferon-alpha in preventing hepatitis C rela ...